Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Parathyroidectomy for patients with renal osteodystrophy].

Yoshihiro Tominaga1

  • 1Department of Surgery, Renal Center, Nagoya 2nd Red Cross Hospital.

Clinical Calcium
|March 19, 2005
PubMed
Summary

Focusing on preventing cardiovascular complications is key for secondary hyperparathyroidism in chronic kidney disease. Parathyroidectomy may be necessary when high PTH levels persist despite other treatments.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Maximal parathyroid gland diameter as a predictive factor for autograft-dependent recurrent secondary hyperparathyroidism after total parathyroidectomy.

Frontiers in endocrinology·2023
Same author

Treatment for secondary hyperparathyroidism focusing on parathyroidectomy.

Frontiers in endocrinology·2023
Same author

Intraoperative intact parathyroid hormone monitoring and frozen section diagnosis are essential for successful parathyroidectomy in secondary hyperparathyroidism.

Frontiers in medicine·2022
Same author

Renal hyperparathyroidism.

Vitamins and hormones·2022
Same author

Elevated parathyroid hormone one year after kidney transplantation is an independent risk factor for graft loss even without hypercalcemia.

BMC nephrology·2022
Same author

Preservation of the nonrecurrent laryngeal nerve using intraoperative nerve monitoring during endoscopic thyroidectomy.

Asian journal of endoscopic surgery·2022

Area of Science:

  • Nephrology
  • Endocrinology
  • Bone Metabolism

Context:

  • Chronic renal failure often leads to secondary hyperparathyroidism (2HPT).
  • Active vitamin D and analogues impact bone turnover in hemodialysis patients.
  • Patients may present with high PTH levels despite normal bone turnover.

Purpose:

  • To shift the focus of managing secondary hyperparathyroidism from bone disease to preventing cardiovascular complications.
  • To evaluate the evolving role of parathyroidectomy in managing refractory hyperparathyroidism.

Summary:

  • The management of secondary hyperparathyroidism (2HPT) in chronic kidney disease is evolving.
  • Cardiovascular complications are now prioritized over osteitis fibrosa.
  • Parathyroidectomy is considered when high PTH levels are difficult to control without increasing the calcium-phosphate product.

Impact:

  • This approach aims to reduce cardiovascular risks and extraskeletal symptoms associated with 2HPT.
  • Highlights the importance of individualized treatment strategies for secondary hyperparathyroidism.
  • Informs clinical decisions regarding parathyroidectomy in complex cases.

Related Experiment Videos